Anna Lucia Fallacara
ScholarGPS® ID: 78580728941597
Affiliation History
Discipline
Chemistry
Top Specialties
Medicinal Chemistry | Protein Kinase Inhibitor | Chemical Synthesis | Glioblastoma
Metrics Summary
Publication Count
34
Predicted Citations
858
Predicted h-index
21
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma (journal article) Biomedicines, volume 10, issue 3, pages 659- (2022). |
Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma (journal article) European Journal of Medicinal Chemistry, volume 223 (2021). |
Predictive Gene Signature for Pyrazolopyrimidine Derivative c-Src Inhibitor 10a Sensitivity in Melanoma Cells (journal article) ACS Medicinal Chemistry Letters, volume 11, issue 5, pages 928-932 (2020). |
Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines (journal article) European Journal of Medicinal Chemistry, volume 181 (2019). |
Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line (journal article) International Journal of Molecular Sciences, volume 20, issue 19, pages 4745- (2019). |
An Update on JAK Inhibitors (journal article) Current Medicinal Chemistry, volume 26, issue 10, pages 1806-1832 (2019). |
Cancers, volume 11, issue 6, pages 848- (2019). |
49. Combined treatments with Hadrontherapy – in vitro tests and preclinical approach (journal article) Physica Medica, volume 56 (2018). |
One-Pot Synthesis of spiro(indoline-3,4′-pyrazolo[3,4-b]pyridine)-5′-carbonitriles As p53-MDM2 Interaction Inhibitors (journal article) Future Medicinal Chemistry, volume 10, issue 24, pages 2771-2789 (2018). |
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment (journal article) Bioorganic & Medicinal Chemistry Letters, volume 28, issue 21, pages 3454-3457 (2018). |
Journal of the Siena Academy of Sciences, volume 9, issue 1 (2018). |
Molecules, volume 23, issue 9, pages 2369- (2018). |
Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction (journal article) European Journal of Medicinal Chemistry, volume 157 (2018). |
Pyrrolo[2,3- d ]pyrimidines active as Btk inhibitors (journal article) Expert Opinion on Therapeutic Patents, volume 27, issue 12, pages 1305-1318 (2017). |
Application of Molecular Modelling to Speed-up the Lead Discovery Process (book chapter) In Computational Tools for Chemical Biology The Royal Society of Chemistry (2017) |
Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors (journal article) Current Medicinal Chemistry, volume 24, issue 999, pages 1-1 (2017). |
Prodrugs of Pyrazolo[3,4- d ]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model (journal article) Journal of Medicinal Chemistry, volume 60, issue 14, pages 6305-6320 (2017). |
Bioorganic & Medicinal Chemistry Letters, volume 27, issue 14, pages 3196-3200 (2017). |
Identification of new pyrrolo[2,3- d ]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma (journal article) European Journal of Medicinal Chemistry, volume 127 (2017). |
Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma (journal article) MedChemComm, volume 8, issue 1, pages 88-95 (2017). |